Tuberculosis screening in Portuguese healthcare workers using the tuberculin skin test and the interferon-γ release assay

European Respiratory Journal

Volumn 34, Issue 6, 2009, Pages 1423-1428

  Costa, J Torres ^a,b   Sa R ^a   Cardoso, M J ^a,b   Silva, R ^a,b   Ferreira, J ^a   Ribeiro, C ^a   Miranda, M ^a,b   Placido J L ^a   Nienhaus, A ^c  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c Institution for Statutory Accident Insurance and Prevention   (Germany)

Author keywords

Healthcare workers; Interferon release assay; Portugal; Tuberculin skin test; Tuberculosis

Indexed keywords

GAMMA INTERFERON;

ADOLESCENT; ADULT; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PORTUGAL; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; BCG VACCINE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PERSONNEL; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL EXPOSURE; PORTUGAL; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS;

EID: 73249136525     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00053809     Document Type: Article

References (27)

1. Jensen PA, Lambert LA, Iademarco MF, et al. Guidelines for preventing the transmission of Mycobacterium tuberculosis in Healthcare Settings, 2005. MMWR 2005; 54: 1-141.
2. Menzies D. What does tuberculin reactivity after Bacille Calmette-Guerin vaccination tell us? Clin Infect Dis 31, 2000: Suppl. 3, S71-S74.
3. Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-1104.
4. Nahid P, Pai M, Hopewell PC. Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc 2006; 3: 103-110.
5. Pai M, Riley LW, Colford JM. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761-776.
6. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-352.
7. Diel R, Loddenkemper R, Meywald-Walter K, et al. Predictive value of a whole blood IFN-γ assay for the development of active TB disease. Am J Respir Crit Care Med 2008; 177: 1164-1170.
8. Harada N, Nakajima Y, Higuchi K, et al. Screening for tuberculosis infection using whole-blood interferon-γ and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006; 27: 442-448.
9. Soberg B, Andersen AB, Larsen HK, et al. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific INF-γ whole-blood test. Scand J Infect Dis 2007; 39: 554-559.
10. Kobashi Y, Obase Y, Fukuda M, et al. Usefulness of QuantiFERON TB-2G, a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers. Intern Med 2007; 46: 1543-1549.
11. Mirtskhulava V, Kempker R, Shields KL, et al. Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia. Int J Tuberc Lung Dis 2008; 12: 513-519.
12. Nienhaus A, Schablon A, Siano B, et al. Evaluation of the interferon-gamma release assay in healthcare workers. Int Arch Occup Environ Health 2008; 81: 295-300.
13. Schablon A, Beckmann G, Harling M, et al. Prevalence of latent tuberculosis infection among healthcare workers in a hospital for pulmonary diseases. J Occup Med Toxicol 2009; 4: 1.
14. Vinton P, Mihrshahi S, Johnson P, et al. Comparison of QuantiFERON-TB Gold In-Tube test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Control Hosp Epidemiol. 2009; 30: 215-221.
15. National Vaccination Plan: Programa Nacional de Vacinaçã o. Direcção-Geral da Saúde - Ministério da Saúde www.dgsaude.pt/upload/membro.id/ficheiros/i007442.pdf Last accessed: May 1, 2009.
16. Hosmer D, Lemeshow S. Applied Logistic Regression. New York, John Wiley & Sons, 2000.
17. WHO Report 2008. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO/HTM/TB/2008.393.
18. Farhat M, Greenaway, Pai M, et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 2006; 10: 1192-1204.
19. Nienhaus A, Schablon A, Diel R. Interferon-γ release assay for the diagnosis of latent TB infection - analysis of discordant results, when compared to the tuberculin skin test. PLoS ONE 2008; 3: e2665.
20. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit CareMed 1999; 159: 15-21.
21. Leyten EMS, Prins C, Bossink AWJ, et al. Effect of tuberculin skin testing on a Mycobacterium tuberculosis specific interferon-γ assay. Eur Respir J 2007; 29: 1212-1216.
22. Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis 2007; 11: 593-605.
23. Seidler A, Nienhaus A, Diel R. Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas. Respiration 2005; 72: 431-446.
24. Saleiro S, Santos AR, Vidal O, et al. Tuberculosis in hospital department health care workers. Revista Portuguesa de Pneumologia 2007; 13: 789-799.
25. Diel R, Seidler A, Nienhaus A, et al. Occupational risk of tuberculosis transmission in a low incidence area. Respir Res 2005; 6: 35-45.
26. De Vries G, Sebek MM, Lambregts-van Weezenbeek CS. Healthcare workers with tuberculosis infected during work. Eur Respir J 2006; 28: 1216-1221.
27. Lee S S-J, Liu Y-C, Huang T-S, et al. Comparison of the interferon-γ release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers. Scandinavian Journal of Infectious Disease 2008; 40: 373-380.